JCDS .0013-13%-CO-UPDATE-SALES-1/7 JC Data Solutions

New Post Public Reply Private Reply Replies (1) Message Board
FLA

JCDS .0013-13%-CO-UPDATE-SALES-1/7

JC Data Solutions Company Update       12/28 09:30 AM



DALLAS, TX -- (MARKETWIRE) -- 12/28/12 -- JC Data Solutions (JCDS:$0.0013,$-0.0002,-13.33%) , is a provider of innovative and cost-effective solutions for digital data processing and management focusing on the Oil & Gas, Legal and Healthcare industries.
Our Payment Manager™ software and service continues to expand and until recently has been the supporting core of our business and its development efforts.
JC Data Solutions (JCDS:$0.0013,$-0.0002,-13.33%) has been in the process of developing two new products over the last two years for both the Oil & Gas and Healthcare industries. JCDS teamed with other companies to develop these new products. Because of this teaming, two new companies have been formed both 50% owned by JCDS.
Claims Expeditors, LLC was formed with Turbo Claims and Aeris Solutions, LLC was formed with Pago Solutions. Aeris Solutions' product is still in development and is scheduled for completion by the end of April, 2013. This product, a variation of the Payment Manager™ system, is designed to support state and federal land lease bids for the oil and gas industry. We are excited about the potential of this new product and as it nears completion more information will be released.
Claims Expeditors, LLC has developed Appeal Manager™ which is designed to facilitate the collection of zero or partial paid claims from independent insurance companies. By utilizing patient information, the Explanation of Benefits and the Summary Plan Description, Appeal Manager™ presents the required information along with federal regulations, namely ERISA, to the insurance companies in a systematic way to recover those uncollected funds.
This product is set for release January 7th, 2013 and has several healthcare clinics already committed for the online service. Claims Expeditors has contracted the services of a sales force that has offices throughout the U.S. More information will be released as we roll out this product.
"We have been focused on the growth of our business over the last few years and we are eager to start putting our long efforts of development in releasing Appeal Manager™ to the market place. With the success of our Payment Manager™ product over the last several years, Appeal Manager™ is a welcomed addition. The development of both new products encountered unforeseen delays which lead to the delay in releasing any of this information to the public. We are still a non-reporting Pinksheets company but hope to release unaudited financials before the end of our fiscal year, June 30th, 2013," says Cary Allen, CEO, JC Data Solutions, Inc. (JCDS:$0.0013,$-0.0002,-13.33%)
Forward-Looking Statements
This press release contains "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Statements in this release that are "forward-looking statements" are based on current expectations and assumptions that are subject to known and unknown risks, uncertainties or other factors which may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Actual results could differ materially because of factors such as: the effect of general economic and market conditions, entry into markets with vigorous competition, market acceptance of new products and services, continued acceptance of existing products and services, technological shifts, and delays in product development and related product release schedules, any of which may cause revenues and income to fall short of anticipated levels.
All information in this release is as of the date of this release.
For Information go to our web site at www.jcdata.com or call:
Cary Allen
CEO
JC Data Solutions, Inc. (JCDS:$0.0013,$-0.0002,-13.33%)
682-429-0523
Email Contact


Get more news on:SYMBOLS: JCDSNEWS TYPE: SECTORS: Information Technology, Computers and Peripherals

I ONLY POST WHAT I PLAY
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 184

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 262

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 192

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 427

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading

Top 5 Most Recently Viewed Articles

Affordable Technology Solutions with Human-I-T's Initiative

Updated Category News Views 184

Human-I-T Launches 'Get It Done' Initiative to Bridge Digital Divide Human-I-T has unveiled its new 'Get It Done' Initiative aimed at making essential technology accessible to everyone without straining their finances. This program focuses on providing quality refurbished laptops at an affordable price, ensuring that individuals and families can benefit from reliable...

Continue Reading
Jasper Street Launches Activism Defense Practice with New Partners

Updated Category News Views 125

Jasper Street Partners Strengthens Activism Defense Practice Jasper Street Partners is gearing up to enhance its defense against activist investors by bringing on board two experienced bankers. Their main objective is clear: to assist clients in identifying weaknesses, navigating proxy contests, and managing the pressures that come with public activism. Introducing New...

Continue Reading
Royalty Pharma's $300 Million Partnership with Zenas BioPharma

Updated Category News Views 139

Funding Agreement for Obexelimab Development Royalty Pharma plc and Zenas BioPharma, Inc. have joined forces in a groundbreaking funding agreement that could inject up to $300 million into the development of obexelimab, a promising treatment for autoimmune diseases, specifically IgG4-Related Disease (IgG4-RD). This alliance highlights Royalty Pharma’s commitment to...

Continue Reading
KBR, Inc. Shares Drop Significantly Following Contract News

Updated Category News Views 242

Significant Decline in KBR, Inc. Shares KBR, Inc. (NYSE: KBR) recently faced a substantial decline in its stock value. This shift came after the announcement regarding the termination of a key contract, leaving many investors anxious about the company's future prospects. The market reacted sharply, indicating the level of uncertainty surrounding KBR's operations and...

Continue Reading
Dr. Mike Varshavski to Address Medical Misinformation Soon

Updated Category News Views 407

Dr. Mike Varshavski to Discuss Medical Misinformation The National Press Club is set to host a compelling event featuring Dr. Mikhail "Dr. Mike" Varshavski, a well-known physician and a social media phenomenon. This exciting Headliners event will take place soon, and attendees can expect an engaging dialogue focused on vital issues surrounding medical misinformation and...

Continue Reading